Showing results (1-10 of 936) with videos related to
Sort By:
Pageof 94
Immunotherapy|June 28, 2017
The future of immune checkpoint cancer therapy after PD-1 and CTLA-4Andrew W Hahn, David M Gill, Sumanta K Pal, et al.Journal of Geriatric Oncology|June 5, 2018
Treatment of metastatic renal cell carcinoma in older patients: A network meta-analysisPeter Hale, Andrew W Hahn, Nityam Rathi, et al.Current Treatment Options in Oncology|February 5, 2015
Sequencing systemic therapies for metastatic kidney cancerParminder Singh, Neeraj Agarwal, Sumanta K PalTherapeutic Advances in Medical Oncology|August 3, 2016
CYP17 inhibitors in prostate cancer: latest evidence and clinical potentialAnitha B Alex, Sumanta K Pal, Neeraj AgarwalCancer Treatment and Research Communications|February 7, 2021
Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experienceUmang Swami, Petros Grivas, Sumanta K Pal, et al.Future Oncology (London, England)|January 10, 2015
Ipilimumab in the treatment of prostate cancerZachary Reese, Ali Straubhar, Sumanta K Pal, et al.Future Oncology (London, England)|August 4, 2015
Development of PROSTVAC immunotherapy in prostate cancerParminder Singh, Sumanta K Pal, Anitha Alex, et al.Current Oncology Reports|February 25, 2015
Activin receptor inhibitors--dalanterceptShilpa Gupta, David Gill, Sumanta K Pal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2017
Sarcomatoid Renal Cell Carcinoma: The Apple Doesn't Fall Far from the TreePaulo Bergerot, Neeraj Agarwal, Sumanta K Pal, et al.Cancer|August 7, 2020
Immunotherapy-based combination strategies for advanced urothelial cancer: A long questAli Raza Khaki, Neeraj Agarwal, Sumanta K Pal, et al.Pageof 94